Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RTI SURGICAL, INC.RTIX · Entity 159205 | EVP CCO-Domestic Direct | February 28, 2018 | March 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RTI SURGICAL, INC.
Report date February 28, 2018 · Filed March 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 146,015 |
Reported balance
After 2018-02-28 transaction · row 1
1 source rowRow 1 · 2018-02-28 · Grant · Acquired 19,800 · Balance 146,015 F1: The Restricted Stock Award will become vested as to 6,600 on each of 2/28/2019, 2/28/2020 and 2/28/2021. |
| Option to purchase common stock $.001 par valueSEC Table II · derivative / convertible security · Conversion / exercise price $4.25 · Expires 2028-02-28 | Direct | 43,600 |
Reported balance
After 2018-02-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-02-28 · Grant · Acquired 43,600 · Balance 43,600 F2: This option will become exercisable as to 8,720 shares on each of 2/28/2019, 2/28/2020, 2/28/2021, 2/28/2022 and 2/28/2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Award will become vested as to 6,600 on each of 2/28/2019, 2/28/2020 and 2/28/2021.
F2: This option will become exercisable as to 8,720 shares on each of 2/28/2019, 2/28/2020, 2/28/2021, 2/28/2022 and 2/28/2023.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Xtant Medical Holdings, Inc.
Report date August 15, 2024 · Filed August 19, 2024
Section 16 reporting ended · disclosed 2024-08-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 943,736 |
Reported balance
After 2024-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-08-15 · Tax withholding · Disposed 56,333 · Balance 943,736 F1: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards. F2: Includes an aggregate of 274,584 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 245,568 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
F2: Includes an aggregate of 274,584 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 245,568 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2024 Filed Aug 19, 2024 16:26 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | Tax withholdingCommon Stock | 56,333 | $0.60 | $33,799.80 |
DisclosureSEC source: 0001235802-24-000066 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 943,736 F1 · kind: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards. F1 · shares: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards. F2 · balance_after: Includes an aggregate of 274,584 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 245,568 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 16:37 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock | 184,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-24-000030 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,069 F1 · shares: These shares will vest and be issued with respect to 46,052 shares on each of April 3, 2025, April 3, 2026, and April 3, 2027 and with respect to 46,053 shares on April 3, 2028 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. F2 · balance_after: Includes an aggregate of 304,708 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting dates. Read SEC document |
| November 17, 2023 Filed Nov 17, 2023 16:42 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | PurchaseCommon Stock | 41,670 | $1.20 | $49,837.32 |
DisclosureSEC source: 0001235802-23-000112 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 815,860 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.228, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 16:46 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 140,583 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001235802-23-000095 · primary_doc.xml · derivative · entry 3 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,583 Underlying: Common Stock · 140,583 shares Expires 2033-08-15 F3 · derivative.exercise_date: This option vests with respect to 35,146 shares on August 15, 2024 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 16:46 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | Tax withholdingCommon Stock | 49,880 | $1.18 | $58,858.40 |
DisclosureSEC source: 0001235802-23-000095 · primary_doc.xml · nonDerivative · entry 2 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774,190 F2 · balance_after: Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 16:46 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock | 120,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-23-000095 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 824,070 F1 · shares: These shares will vest and be issued with respect to 30,125 shares on each of August 15, 2024, August 15, 2025 and August 15, 2026 and with respect to 30,124 shares on August 15, 2027 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. F2 · balance_after: Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates. Read SEC document |
| August 17, 2022 Filed Aug 17, 2022 17:28 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | SaleCommon Stock, $0.000001 par value | 4,300 | $0.48 | $2,049.38 |
DisclosureSEC source: 0001235802-22-000101 · primary_doc.xml · nonDerivative · entry 3 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,571 F3 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.47 to $0.4953, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F2 · balance_after: Includes 588,046 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 17:28 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | SaleCommon Stock, $0.000001 par value | 18,700 | $0.49 | $9,172.35 |
DisclosureSEC source: 0001235802-22-000101 · primary_doc.xml · nonDerivative · entry 2 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 707,871 F3 · kind: These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.47161 to $0.52, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F2 · balance_after: Includes 588,046 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 17:28 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 410,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-22-000101 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 726,571 F1 · shares: These shares will vest and be issued with respect to 102,520 shares on each of August 15, 2023, August 15, 2024 and August 15, 2025 and with respect to 102,519 shares on August 15, 2026 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan. F2 · balance_after: Includes 588,046 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 17:32 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 199,519 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001235802-21-000108 · primary_doc.xml · derivative · entry 3 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,519 Underlying: Common Stock · 199,519 shares Expires 2031-08-15 F3 · derivative.exercise_date: This option vests with respect to 49,879 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 17:32 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | Tax withholdingCommon Stock, $0.000001 par value | 7,169 | $1.20 | $8,602.80 |
DisclosureSEC source: 0001235802-21-000108 · primary_doc.xml · nonDerivative · entry 2 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,492 F2 · balance_after: Includes 251,081 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 17:32 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 162,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-21-000108 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,661 F1 · shares: These shares will vest and be issued with respect to 40,527 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 40,528 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. F2 · balance_after: Includes 251,081 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 17:03 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | Tax withholdingCommon Stock, $0.000001 par value | 8,800 | $1.74 | $15,312.00 |
DisclosureSEC source: 0001235802-21-000075 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,552 F1 · balance_after: Includes 121,560 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
| August 15, 2020 Filed Aug 18, 2020 20:15 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 119,942 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001235802-20-000097 · primary_doc.xml · derivative · entry 2 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,942 Underlying: Common Stock · 119,942 shares Expires 2030-08-15 F3 · derivative.exercise_date: This option vests with respect to 29,986 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments., subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. Read SEC document |
| August 15, 2020 Filed Aug 18, 2020 20:15 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 95,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-20-000097 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,352 F1 · shares: These shares will vest and be issued with respect to 23,796 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023 and with respect to 23,795 shares on August 15, 2024 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. F2 · balance_after: Includes 161,560 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:20 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 40,527 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001235802-19-000104 · primary_doc.xml · derivative · entry 2 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,527 Underlying: Common Stock · 40,527 shares Expires 2029-08-15 F3 · derivative.exercise_date: This option vests with respect to 10,131 shares on August 15, 2020 and with respect to 10,132 shares on each of August 15, 2021, August 15, 2022 and August 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:20 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 35,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-19-000104 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,169 F1 · shares: These shares will vest and be issued with respect to 8,792 shares on each of August 15, 2020, August 15, 2021 and August 15, 2022 and with respect to 8,793 shares on August 15, 2023 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. F2 · balance_after: These shares will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 16:54 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 30,770 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001235802-18-000122 · primary_doc.xml · derivative · entry 2 Brandt Kevin D · CIK 0001692661 · VP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,770 Underlying: Common Stock · 30,770 shares Expires 2028-08-15 F2 · derivative.exercise_date: This option vests with respect to 7,692 shares on each of August 15, 2019 and August 15, 2020 and with respect to 7,693 shares on each of August 15, 2021 and August 15, 2022, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 16:54 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantCommon Stock, $0.000001 par value | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-18-000122 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · VP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · shares: These shares will vest and be issued on July 9, 2021 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. F1 · balance_after: These shares will vest and be issued on July 9, 2021 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 10:26 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantOption to purchase common stock $.001 par value · Derivative | 43,600 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001692661-18-000001 · primary_doc.xml · derivative · entry 2 Brandt Kevin D · CIK 0001692661 · EVP CCO-Domestic Direct 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,600 Underlying: Common Stock · 43,600 shares Expires 2028-02-28 F2 · derivative.exercise_date: This option will become exercisable as to 8,720 shares on each of 2/28/2019, 2/28/2020, 2/28/2021, 2/28/2022 and 2/28/2023. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 10:26 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantCommon Stock | 19,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001692661-18-000001 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · EVP CCO-Domestic Direct 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,015 F1 · shares: The Restricted Stock Award will become vested as to 6,600 on each of 2/28/2019, 2/28/2020 and 2/28/2021. Read SEC document |
| May 03, 2017 Filed May 4, 2017 15:32 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | PurchaseCommon Stock | 33,130 | $4.52 | $149,747.60 |
DisclosureSEC source: 0001692661-17-000002 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · EVP CCO-Domestic Direct 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,215 Read SEC document |
| January 24, 2017 Filed Jan 30, 2017 12:00 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantOption to purchase common stock $.001 par value · Derivative | 62,500 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001692661-17-000001 · primary_doc.xml · derivative · entry 2 Brandt Kevin D · CIK 0001692661 · EVP CCO-Domestic Direct 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2027-01-24 F1 · derivative.exercise_date: This option will become exercisable as to 12,500 shares on each of 1/24/2018, 1/24/2019, 1/24/2020, 1/24/2021 and 1/24/2022. Read SEC document |
| January 24, 2017 Filed Jan 30, 2017 12:00 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001692661-17-000001 · primary_doc.xml · nonDerivative · entry 1 Brandt Kevin D · CIK 0001692661 · EVP CCO-Domestic Direct 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,085 F2 · shares: The Restricted Stock award will become vested as to 20,833 shares on both 1/24/2018 and 1/24/2019 and 20,834 shares on 1/24/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.